share_log

Marpai | 10-Q: Quarterly report

Marpai | 10-Q: Quarterly report

Marpai | 10-Q:季度报表
美股SEC公告 ·  11/12 09:26

Moomoo AI 已提取核心信息

Marpai, Inc., a technology-driven healthcare third-party administrator, reported a decrease in revenue for the quarter ended September 30, 2024, with total revenue falling to $7.008 million from $8.729 million in the same period last year, marking a 19.7% decline. The company's net loss improved, however, from $7.296 million to $3.560 million, a 51.2% reduction. The decrease in revenue was attributed to customer turnover, while the reduction in net loss was due to cost-saving measures and the alignment of two TPA companies into one. Operating expenses also saw a significant decrease, with general and administrative expenses dropping by 43.6% to $2.813 million, and sales and marketing expenses reducing by 81.3% to $345 thousand. The company also reported an impairment charge of $7.588 million for goodwill and intangible assets. Marpai's...Show More
Marpai, Inc., a technology-driven healthcare third-party administrator, reported a decrease in revenue for the quarter ended September 30, 2024, with total revenue falling to $7.008 million from $8.729 million in the same period last year, marking a 19.7% decline. The company's net loss improved, however, from $7.296 million to $3.560 million, a 51.2% reduction. The decrease in revenue was attributed to customer turnover, while the reduction in net loss was due to cost-saving measures and the alignment of two TPA companies into one. Operating expenses also saw a significant decrease, with general and administrative expenses dropping by 43.6% to $2.813 million, and sales and marketing expenses reducing by 81.3% to $345 thousand. The company also reported an impairment charge of $7.588 million for goodwill and intangible assets. Marpai's liquidity remains a concern, with an accumulated deficit of approximately $97.7 million and negative working capital of approximately $3.3 million. The company is exploring strategic alternatives to maximize shareholder value, which may include a sale, merger, or strategic investment financing. Marpai's financial performance is also impacted by its reliance on a major customer, which accounted for 14.6% of total revenue for the quarter. The company's cash flows from operations were negative at $10.251 million, a decrease from the previous year's $15.324 million. Marpai's management has acknowledged substantial doubt about the company's ability to continue as a going concern and is seeking additional funding to support ongoing operations.
Marpai公司是一家以科技驱动的医疗第三方管理机构,报告截至2024年9月30日的季度营业收入下降,整体营业收入从去年同期的872.9万下降至700.8万,下降幅度为19.7%。然而,该公司的净亏损有所改善,从729.6万减少至356万,减少幅度为51.2%。营业收入的下降归因于客户流失,而净亏损的减少则是由于节约成本措施和将两家TPA公司合并为一家。营业费用也显著下降,综合与行政费用减少了43.6%,降至281.3万,销售与市场营销费用减少了81.3%,降至34.5万。公司还报告了758.8万的商誉和无形资产减值损失。Marpai的流动性依然令人担忧,累计赤字约为9770万,负流动资金约为...展开全部
Marpai公司是一家以科技驱动的医疗第三方管理机构,报告截至2024年9月30日的季度营业收入下降,整体营业收入从去年同期的872.9万下降至700.8万,下降幅度为19.7%。然而,该公司的净亏损有所改善,从729.6万减少至356万,减少幅度为51.2%。营业收入的下降归因于客户流失,而净亏损的减少则是由于节约成本措施和将两家TPA公司合并为一家。营业费用也显著下降,综合与行政费用减少了43.6%,降至281.3万,销售与市场营销费用减少了81.3%,降至34.5万。公司还报告了758.8万的商誉和无形资产减值损失。Marpai的流动性依然令人担忧,累计赤字约为9770万,负流动资金约为330万。公司正在探索战略选择,以最大化股东价值,这可能包括出售、合并或战略投资融资。Marpai的财务表现还受到对主要客户依赖的影响,该客户占该季度总营业收入的14.6%。公司的运营现金流为负,达到1025.1万,低于去年同期的1532.4万。Marpai的管理层已承认对公司能否持续经营存在重大怀疑,并正在寻求额外资金以支持持续运营。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息